<!DOCTYPE html>
<html lang="en">
<head>
<?php $id='1951-1224'; include '../../seo.php';?>
<?php include '../../side-nav.php';?>
<div class="page-content">
<!--section-->
<div class="section mt-0">
<div class="breadcrumbs-wrap">
<div class="container">
<div class="breadcrumbs">
<a href="https://sprintdiagnostics.in/">Home</a>
<a href="https://www.sprintdiagnostics.in/hyderabad/test/">Test</a>
<span>AML Cytogenetics 2 (Karyotyping + FISH for AML-ETO + Inv(16) + MLL) </span>
</div>
</div>
</div>
</div>
<!--//section-->
<!--section-->
<div class="section page-content-first">
<div class="container mt-6">
<div class="row">
<div class="col-md-8 col-lg-8 mt-0 mt-md-0 mb-4">
<h1 class="test-h1">AML Cytogenetics 2 (Karyotyping + FISH for AML-ETO + Inv(16) + MLL) </h1>
<div class="post-text">
<p>AML Cytogenetics 2 is a comprehensive diagnostic testing panel that is used for the analysis of patients suspected to have Acute Myeloid Leukemia (AML), a type of cancer affecting the bone marrow and the blood. AML Cytogenetics 2 combines karyotyping with Fluorescence In Situ Hybridization (FISH) tests. Karyotyping is used for examining the number and structure of chromosomes in blood or bone marrow cells. The FISH tests are aimed at identifying specific chromosomal abnormalities associated with AML, including AML-ETO, Inv(16), and MLL. These genetic alterations play a significant role in the diagnosis and categorization of AML and have implications for treatment and prognosis. <br><br>
Acute Myeloid Leukemia is a cancer that initiates in the cells that would generally develop into different types of blood cells. It is characterized by the rapid growth of abnormal white blood cells that accumulate in the bone marrow, interfering with the production of normal blood cells. The AML Cytogenetics 2 testing panel is vital for the diagnosis and management of this disease. </p>

<div class="table-wrap">
<table class="table table-striped">
	<thead>
		<tr>
			<th scope="col">Test Name</th>
			<td scope="col">AML Cytogenetics 2 (Karyotyping + FISH for AML-ETO + Inv(16) + MLL) </td>
		</tr>
	</thead>
	<tbody>
		<tr>
			<th scope="row">Sample Type</th>
			<td>Bone Marrow or Blood </td>
		</tr>
		<tr>
			<th scope="row">Preparations Required</th>
			<td>No special preparation like fasting is needed for this test. However, it is important to inform your doctor about any medications you are currently taking. </td>
		</tr>
		<tr>
			<th scope="row">Report Time</th>
			<td> 12 Days for Karyotype & 5 Days for FISH </td>
		</tr>
		<tr>
			<th scope="row">Price in Hyderabad</th>
			<td>â‚¹ 13250 </td>
		</tr>
	</tbody>
</table>
</div>
<div class="post-text">
	<h2 class="test-h2 mt-3">What is Acute Myeloid Leukemia (AML)? </h2>
	<p>AML is a cancer that affects the bone marrow, leading to the rapid production of abnormal white blood cells. These abnormal cells impede the production of normal blood cells. </p>
	<h2 class="test-h2 mt-3">Why is the AML Cytogenetics 2 panel important? </h2>
	<p> The AML Cytogenetics 2 panel is crucial for the accurate diagnosis and classification of AML. It helps in detecting specific chromosomal abnormalities which are significant in determining the subtype of AML and thus guiding the treatment decisions.</p>
	<!--section achieved-->
	<?php include "../../include/iconsbox.php" ?>
	<!--//section achieved-->
	<h2 class="test-h2 mt-3">What information does the AML Cytogenetics 2 panel provide? </h2>
	<p>This panel provides detailed information regarding chromosomal structure and specific abnormalities such as AML-ETO, Inv(16), and MLL. This information is critical for diagnosing AML, identifying its subtype, and understanding its progression. </p>
	<h2 class="test-h2 mt-3">Is fasting required for this test? </h2>
	<p>No, fasting is not required for the AML Cytogenetics 2 panel. </p>
	<h2 class="test-h2 mt-3">When should I get this test done? </h2>
	<p>This test is generally recommended if you have signs or symptoms suggestive of leukemia or if abnormal blood counts are detected during routine blood tests. It's also used for monitoring the disease during treatment. </p>
	<h2 class="test-h2 mt-3">What are the normal values for this test? </h2>
	<p>In a healthy individual, there should be no chromosomal abnormalities. The presence of the specific abnormalities tested for in this panel is indicative of AML. </p>
	<h2 class="test-h2 mt-3">What factors can affect the test results? </h2>
	<p>Genetic mutations, the presence of leukemia cells, and certain medications can affect the results of this test. </p>
	<h2 class="test-h2 mt-3">How will this test affect my treatment options? </h2>
	<p>The results of this test will help your doctor to tailor the treatment based on the specific subtype of AML, which can be more effective in managing the disease. </p>
	<h2 class="test-h2 mt-3">What doctor should I consult if I have abnormal test results? </h2>
	<p>If the test results are abnormal, it is important to consult a hematologist or oncologist who specializes in blood cancers. </p>
	<h2 class="test-h2 mt-3">Can this test be done at home? </h2>
	<p>No, this test requires a sample of blood or bone marrow, which must be collected in a medical facility. </p>
	<h2 class="test-h2 mt-3">Are there any risks associated with this test? </h2>
	<p>The blood draw is relatively safe but may cause minor pain. When a bone marrow sample is needed, there may be pain at the site of the biopsy. </p>
	<h2 class="test-h2 mt-3">What is FISH and how does it help in the diagnosis of AML? </h2>
	<p>FISH or Fluorescence In Situ Hybridization is a test that maps the genetic material in human cells, including specific genes or portions of genes. In diagnosing AML, it is used to find specific changes in chromosomes and genes that might not be visible under a microscope. </p>
	<h2 class="test-h2 mt-3">What is Inv(16) and why is it significant? </h2>
	<p> Inv(16) is a chromosomal abnormality where part of chromosome 16 is inverted. It is one of the common abnormalities in AML and is associated with a particular subtype of the disease. It has specific implications for prognosis and treatment.</p>
	<h2 class="test-h2 mt-3">How often should I get tested? </h2>
	<p>The frequency of testing depends on various factors including the stage of the disease, the treatment being used, and your overall health. Your doctor will provide guidance on how often you should be tested. <br><br>
Recognizing the genetic alterations in Acute Myeloid Leukemia is imperative for optimal management of the condition. The AML Cytogenetics 2 panel is a highly valuable tool in the diagnostic process and plays a significant role in guiding therapeutic strategies. Continuous communication with your doctor and active participation in the management and treatment plan is essential for the best possible outcomes.
 </p>
	
</div>		
</div>			
</div>
<!--form section-->
<?php include "../../include/bookslot.php" ?>
<!--form section-->
</div>
</div>
<!--//section-->
</div>
</div>
<?php include '../../footer.php';?>
</body>
</html>